Articles with public access mandates - Rachel Kerr (nee Midgley)Learn more
OverallCancer Research UKNIHRMRCNIHWellcomeEuropean CommissionAcademy of FinlandAcademy of Medical Sciences, UKCSORCNWorldwide Cancer Research, UKKWFNHMRCDFGHelmholtzNWOBBSRCBlood Cancer UKGovernment of SpainBMBFGovernment of ItalyDoDCIHRGenome CanadaINSERMSwedish Research CouncilBHFBreast Cancer Now, UKESRCProstate Cancer UKYorkshire Cancer Research, UK
Not available anywhere: 6
'Toxgnostics': an unmet need in cancer medicine
D Church, R Kerr, E Domingo, D Rosmarin, C Palles, K Maskell, ...
Nature Reviews Cancer 14 (6), 440-445, 2014
Mandates: Cancer Research UK, Wellcome Trust
Biomarkers in early-stage colorectal cancer: Ready for prime time?
D Church, R Midgley, D Kerr
Digestive diseases 30 (Suppl. 2), 27-33, 2012
Mandates: Cancer Research UK
Quinone Oxidoreductase-2–Mediated Prodrug Cancer Therapy
MR Middleton, R Knox, E Cattell, U Oppermann, R Midgley, R Ali, T Auton, ...
Science translational medicine 2 (40), 40ra50-40ra50, 2010
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
An open-label study of the safety and tolerability of pazopanib in combination with FOLFOX6 or CapeOx in patients with colorectal cancer
J Brady, P Corrie, I Chau, R Digumarti, LM Adams, J Botbyl, ...
Investigational new drugs 31, 1228-1235, 2013
Mandates: Cancer Research UK
573P Multiparameter immunoprofiling reveals independent prognostic value of intraepithelial CD8 and intrastromal FoxP3 infiltrate in stage II/III colorectal cancer: Analysis of …
DN Church, A Frei, A McGuigan, R Sinha, A Harkin, TJ Iveson, ...
Annals of Oncology 34, S421-S422, 2023
Mandates: Cancer Research UK
568P Single cell AI-based detection of DNA mismatch repair deficiency in 1,988 colorectal cancers reveals prognostic and predictive value in the SCOT trial
F Jabbar, M Nowak, AK Rodewald, L Gneo, T Tomasevic, A Harkin, ...
Annals of Oncology 34, S420, 2023
Mandates: Cancer Research UK, National Institute for Health Research, UK
Available somewhere: 74
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
LYW Lee, JB Cazier, V Angelis, R Arnold, V Bisht, NA Campton, ...
The Lancet 395 (10241), 1919-1926, 2020
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
Genetic prognostic and predictive markers in colorectal cancer
A Walther, E Johnstone, C Swanton, R Midgley, I Tomlinson, D Kerr
Nature Reviews Cancer 9 (7), 489-499, 2009
Mandates: US National Institutes of Health
Duration of adjuvant chemotherapy for stage III colon cancer
A Grothey, AF Sobrero, AF Shields, T Yoshino, J Paul, J Taieb, ...
New England Journal of Medicine 378 (13), 1177-1188, 2018
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma
DH Palmer, RS Midgley, N Mirza, EE Torr, F Ahmed, JC Steele, ...
Hepatology 49 (1), 124-132, 2009
Mandates: Cancer Research UK
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
LYW Lee, JB Cazier, T Starkey, SEW Briggs, R Arnold, V Bisht, S Booth, ...
The Lancet Oncology 21 (10), 1309-1316, 2020
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Deep learning for prediction of colorectal cancer outcome: a discovery and validation study
OJ Skrede, S De Raedt, A Kleppe, TS Hveem, K Liestøl, J Maddison, ...
The Lancet 395 (10221), 350-360, 2020
Mandates: National Institute for Health Research, UK, Research Council of Norway
Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26. 2, 12q13. 13 and 20q13. 33
RS Houlston, J Cheadle, SE Dobbins, A Tenesa, AM Jones, K Howarth, ...
Nature genetics 42 (11), 973-977, 2010
Mandates: Cancer Research UK, Chief Scientist Office, Scottish Executive
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial
SJ Dutton, DR Ferry, JM Blazeby, H Abbas, A Dahle-Smith, W Mansoor, ...
The lancet oncology 15 (8), 894-904, 2014
Mandates: Cancer Research UK
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study
E Domingo, L Freeman-Mills, E Rayner, M Glaire, S Briggs, L Vermeulen, ...
The lancet Gastroenterology & hepatology 1 (3), 207-216, 2016
Mandates: Academy of Medical Sciences, UK, Cancer Research UK, National Institute for …
Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk
MG Dunlop, SE Dobbins, SM Farrington, AM Jones, C Palles, N Whiffin, ...
Nature genetics 44 (7), 770-776, 2012
Mandates: US National Institutes of Health, Swedish Research Council, Cancer Research …
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis
D Rosmarin, C Palles, D Church, E Domingo, A Jones, E Johnstone, ...
Journal of Clinical Oncology 32 (10), 1031-1039, 2014
Mandates: US National Institutes of Health, Cancer Research UK, Wellcome Trust
Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer
E Domingo, DN Church, O Sieber, R Ramamoorthy, Y Yanagisawa, ...
Journal of clinical oncology 31 (34), 4297-4305, 2013
Mandates: Cancer Research UK, Wellcome Trust
Association analyses identify 31 new risk loci for colorectal cancer susceptibility
PJ Law, M Timofeeva, C Fernandez-Rozadilla, P Broderick, J Studd, ...
Nature communications 10 (1), 2154, 2019
Mandates: US National Institutes of Health, German Research Foundation, Helmholtz …
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial
TJ Iveson, RS Kerr, MP Saunders, J Cassidy, NH Hollander, J Tabernero, ...
The Lancet Oncology 19 (4), 562-578, 2018
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Publication and funding information is determined automatically by a computer program